Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Metastatic Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01851824
What this trial is testing

The Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy

Who this might be right for
Malignant Melanoma, Neoplasms
Hoffmann-La Roche 9
Testing effectiveness (Phase 2)Study completedNCT02158520
What this trial is testing

Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaMucosal MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
Academic and Community Cancer Research United 24
Testing effectiveness (Phase 2)Ended earlyNCT00560118
What this trial is testing

Fotemustine in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Institut du Cancer de Montpellier - Val d'Aurelle 12
Large-scale testing (Phase 3)Active Not RecruitingNCT01592968
What this trial is testing

Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases

Who this might be right for
Metastatic Malignant NeoplasmMetastatic Malignant Neoplasm in the Brain
M.D. Anderson Cancer Center 88
Testing effectiveness (Phase 2)Study completedNCT00299689
What this trial is testing

Phase II Trial of Ontak With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
James Graham Brown Cancer Center 69
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Testing effectiveness (Phase 2)Study completedNCT00715793
What this trial is testing

Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hussein Tawbi 39
Early research (Phase 1)Study completedNCT01738139
What this trial is testing

Ipilimumab and Imatinib Mesylate in Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmC-KIT Tyrosine Kinase Protein OverexpressionClinical Stage IV Cutaneous Melanoma AJCC v8+6 more
M.D. Anderson Cancer Center 68
Testing effectiveness (Phase 2)Looking for participantsNCT06265025
What this trial is testing

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerMalignant MelanomaColorectal Cancer+3 more
GeneMedicine Co., Ltd. 125
Testing effectiveness (Phase 2)UnknownNCT01565837
What this trial is testing

Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma

Who this might be right for
Melanoma
Wolfram Samlowski 50
Testing effectiveness (Phase 2)Study completedNCT03873818
What this trial is testing

Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more
M.D. Anderson Cancer Center 24
Not applicableStudy completedNCT06180460
What this trial is testing

CALM: Managing Distress in Malignant Brain Cancer

Who this might be right for
Brain TumorBrain MetastasesBrain Cancer+5 more
Virginia Commonwealth University 60
Early research (Phase 1)Study completedNCT02935790
What this trial is testing

Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab

Who this might be right for
Malignant Melanoma
Celgene 1
Testing effectiveness (Phase 2)Study completedNCT00104988
What this trial is testing

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network 64
Early research (Phase 1)Study completedNCT00978913
What this trial is testing

Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma

Who this might be right for
Breast CancerMalignant Melanoma
Inge Marie Svane 31
Testing effectiveness (Phase 2)UnknownNCT04021420
What this trial is testing

Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma

Who this might be right for
MelanomaMetastatic Melanoma
Assistance Publique - Hôpitaux de Paris 21
Not applicableUnknownNCT03132090
What this trial is testing

Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI

Who this might be right for
Malignant Melanoma Stage IV
University Hospital Tuebingen 106
Testing effectiveness (Phase 2)UnknownNCT00538005
What this trial is testing

Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
San Diego Pacific Oncology & Hematology Associates 54
Testing effectiveness (Phase 2)Study completedNCT02902042
What this trial is testing

Encorafenib + Binimetinib + Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma

Who this might be right for
Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 16
Early research (Phase 1)Study completedNCT01849666
What this trial is testing

The Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy

Who this might be right for
Malignant Melanoma, Neoplasms
Hoffmann-La Roche 2
Next Page